Literature DB >> 17514504

Measuring illness management outcomes: a psychometric study of clinician and consumer rating scales for illness self management and recovery.

Michelle P Salyers1, Jenna L Godfrey, Kim T Mueser, Shauna Labriola.   

Abstract

Psychometric properties of the Illness Management and Recovery (IMR) Scales (consumer and clinician versions), new 15-item instruments measuring illness self-management and pursuit of recovery goals, were evaluated in consumers with severe mental illness. Both versions had moderate internal consistency and high 2-week test-retest reliability. In addition, the consumer version was correlated with self-ratings of recovery and symptoms, and the clinician version was correlated with clinician ratings of community functioning, indicating convergent validity. The results suggest the IMR Scales have adequate psychometric properties and may be useful in treatment planning and assessing recovery in individuals with severe mental illness.

Entities:  

Mesh:

Year:  2007        PMID: 17514504     DOI: 10.1007/s10597-007-9087-6

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  18 in total

1.  Implementing evidence-based practices in routine mental health service settings.

Authors:  R E Drake; H H Goldman; H S Leff; A F Lehman; L Dixon; K T Mueser; W C Torrey
Journal:  Psychiatr Serv       Date:  2001-02       Impact factor: 3.084

2.  What recovery means to us: consumers' perspectives.

Authors:  S Mead; M E Copeland
Journal:  Community Ment Health J       Date:  2000-06

3.  The Illness Management and Recovery program: rationale, development, and preliminary findings.

Authors:  Kim T Mueser; Piper S Meyer; David L Penn; Richard Clancy; Donna M Clancy; Michelle P Salyers
Journal:  Schizophr Bull       Date:  2006-08-09       Impact factor: 9.306

4.  A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

Authors:  G J McHugo; R E Drake; H L Burton; T H Ackerson
Journal:  J Nerv Ment Dis       Date:  1995-12       Impact factor: 2.254

5.  A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity.

Authors:  S Barker; N Barron; B H McFarland; D A Bigelow
Journal:  Community Ment Health J       Date:  1994-08

6.  Recovery as a psychological construct.

Authors:  P W Corrigan; D Giffort; F Rashid; M Leary; I Okeke
Journal:  Community Ment Health J       Date:  1999-06

7.  Implementing evidence-based practices for people with severe mental illness.

Authors:  Kim T Mueser; William C Torrey; David Lynde; Patricia Singer; Robert E Drake
Journal:  Behav Modif       Date:  2003-07

8.  Training skills in the psychiatrically disabled: learning coping and competence.

Authors:  R P Liberman; K T Mueser; C J Wallace; H E Jacobs; T Eckman; H K Massel
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

9.  Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications.

Authors:  Alan S Bellack
Journal:  Schizophr Bull       Date:  2006-02-03       Impact factor: 9.306

10.  Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.

Authors:  K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

View more
  32 in total

1.  Disability and self-management practices of people with bipolar disorder: a web-based survey.

Authors:  Colin A Depp; John L Stricker; David Zagorsky; Lisa C Goodale; Lisa T Eyler; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste
Journal:  Community Ment Health J       Date:  2008-12-06

Review 2.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

3.  Integrating assertive community treatment and illness management and recovery for consumers with severe mental illness.

Authors:  Michelle P Salyers; Alan B McGuire; Angela L Rollins; Gary R Bond; Kim T Mueser; Veronica R Macy
Journal:  Community Ment Health J       Date:  2010-01-14

4.  The role of patient activation in psychiatric visits.

Authors:  Michelle P Salyers; Marianne S Matthias; Crystal L Spann; Jennifer M Lydick; Angela L Rollins; Richard M Frankel
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

5.  Mental Health Recovery in the Patient-Centered Medical Home.

Authors:  Marisa Sklar; Gregory A Aarons; Maria O'Connell; Larry Davidson; Erik J Groessl
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

6.  Measuring the later stages of the recovery journey: insights gained from clubhouse members.

Authors:  Nicola Hancock; Anita Bundy; Anne Honey; Stephanie Helich; Sally Tamsett
Journal:  Community Ment Health J       Date:  2012-07-24

7.  Measuring participation in an evidence-based practice: illness management and recovery group attendance.

Authors:  Alan B McGuire; Kelsey A Bonfils; Marina Kukla; Laura Myers; Michelle P Salyers
Journal:  Psychiatry Res       Date:  2013-09-05       Impact factor: 3.222

8.  Consumer factors predicting level of treatment response to illness management and recovery.

Authors:  Dominique A White; Alan B McGuire; Lauren Luther; Adrienne I Anderson; Peter Phalen; John H McGrew
Journal:  Psychiatr Rehabil J       Date:  2017-09-14

9.  Integrated IMR for psychiatric and general medical illness for adults aged 50 or older with serious mental illness.

Authors:  Stephen J Bartels; Sarah I Pratt; Kim T Mueser; John A Naslund; Rosemarie S Wolfe; Meghan Santos; Haiyi Xie; Erik G Riera
Journal:  Psychiatr Serv       Date:  2014-03-01       Impact factor: 3.084

10.  A real-life observational study of the effectiveness of FACT in a Dutch mental health region.

Authors:  Marjan Drukker; Myrte Maarschalkerweerd; Maarten Bak; Ger Driessen; Joost à Campo; Arthur de Bie; Giovanni Poddighe; Jim van Os; Philippe Delespaul
Journal:  BMC Psychiatry       Date:  2008-12-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.